By Delois Howell, RN, BSN, CCM, LHRM, and Lily Willson, RN, BSN, CCM, ARA, ACS Medical Risk Consultants for Symetra Life Insurance Co.
As we have explored in previous articles1, chronic kidney disease (CKD) is a costly health care concern for many Americans. Like many medical conditions, the key to the prevention of CKD is early detection. At each stage of the disease, there are opportunities and preventative actions that can be taken to improve patients’ outcomes. Working together, we can identify the best approaches to managing this high-cost and catastrophic disease.
The two main causes of chronic kidney disease are diabetes and high blood pressure. Early patient education and detection is essential to managing the disease. Employer Wellness programs and health care screenings and assessments can be effective in early detection. Case management and disease management play pivotal roles in preventing and delaying the disease’s progression to kidney failure.
Working together
Symetra has partnered with many providers and healthcare organizations to assist in the management of chronic kidney disease. Our team of Medical Risk Consultants (MRCs) is a resource for cost containment efforts and helps support the transition from patient education to dialysis and transplantation.
The five stages of chronic kidney disease serve as windows of opportunities to manage the disease progression, reduce cost of treatment, and lessen the impact of large claims. With early identification and joint management of the disease and dialysis claims, third-party administrators (TPAs) and Symetra can work together to improve the outcome for the patient, preserve the lifetime benefit of the member and realize significant savings for the policyholder.
Here are some examples of how TPAs and Symetra MRCs work together throughout the five stages of CKD. (Click here for a printable version of this chart.)
|